TRAINERS' HOUSE PLC’S FINANCIAL REPORTING IN 2023
TRAINERS' HOUSE GROUP, STOCK EXCHANGE RELEASE, 21 NOVEMBER 2022 at 9:30
Trainers' House Plc's Financial Statements Bulletin 2022 will be published on Thursday 23 February 2023.
The Annual General Meeting is planned to be held on Wednesday 29 March 2023.
The financial reports for 2023 will be published as follows:
27 April 2023 at 8:30 Interim Report 1 January – 31 March 2023
20 July 2023 at 8:30 Half Year Financial Report 1 January – 30 June 2023
26 October 2023 at 8:30 Interim Report 1 January -30 September 2023
TRAINERS' HOUSE PLC
Saku Keskitalo, tel. +358 404 111 111
CFO
DISTRIBUTION
Nasdaq Helsinki
Main media
www.trainershouse.fi – For investors
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Volta Finance Limited - Director/PDMR Shareholding1.5.2024 15:55:24 CEST | Press release
Volta Finance Limited (VTA/VTAS) Notification of transactions by directors, persons discharging managerial responsibilities and persons closely associated with them NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ***** Guernsey, 1 May 2024 Pursuant to the announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors fees, Volta Finance Limited (the “Company” or “Volta”) has purchased 3,491 ordinary shares of no par value in the Company (“Ordinary Shares”) at an average price of €4.90 per share. Each director receives 30% of their Director’s fees for any year in the form of shares, which they are required to retain for a period of no less than one year from their respective date of issue. The shares will be issued to the Directors, who for the purposes of Regulation (EU) No 596/2014 on Market Abuse ("MAR") are "persons discharging managerial responsibilities" (a "PDMR"). Dagmar Kershaw, Chairman and a
Reporting of transactions made by members of the Board of Directors or Executive Management or their Closely Associated Persons1.5.2024 15:38:29 CEST | Press release
Pursuant to the Market Abuse Regulation, article 19, Svitzer Group A/S, CVR-no. 44 79 14 47, (“Svitzer Group” or the “Company”) hereby notifies receipt of information of the following transactions made by members of the Board of Directors or Executive Management in Svitzer Group or their closely associated persons in Svitzer Group’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S. About Svitzer Svitzer is a leading, global towage and marine services provider. The core business is to assist large seaborne vessels in manoeuvring in and out of ports and terminals to berth and unberth. With more than 450 vessels, Svitzer’s services play a crucial role as part of critical port infrastructure. Svitzer was founded in 1833 and serves approximately 2,000 customers in more than 140 ports and 40 terminals across 37 countries. Read more on www.svitzer.com. For further information, please contact: Anders Crillesen Head of Global Communications E: anders.crillesen@svitzer.co
Suspension af udvalgte afdelinger den 6. maj 20241.5.2024 14:52:03 CEST | pressemeddelelse
Det skal oplyses, at nedenstående afdelinger vil være suspenderet for handel mandag den 6. maj 2024. ISINOrder book codeAfdelingsnavn før ændringAfdelingsnavn efter ændringDK0060254043SPVINONye obligationsmarkederINDEX Emerging Market Bonds LokalvalutaDK0060254126SPVINOAKKKLANye obligationsmarkeder Akk. – KL AINDEX Emerging Market Bonds Lokalvaluta Akk. – KL A Suspension af disse afdelinger kommer i forlængelse af tidligere fondbørsmeddelelse den 19. april 2024 vedrørende ædnringer i ovenstående fonde. Det vurderes, at det ikke er hensigtmæssigt at stille priser i markedet på ovenstående afdelinger den 6. maj 2024, hvorfor suspensionen forlænges til og med denne dag. Eventuel henvendelse vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk, cc jna@nykredit.dk Med venlig hilsen Morten Skipper Direktør, ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg
Alternus Clean Energy set to Acquire Over 80 MWp of Operating Solar PV across eight states in the U.S.1.5.2024 14:40:00 CEST | Press release
On completion will be immediately EBITDA accretive FORT MILL, S.C., May 01, 2024 (GLOBE NEWSWIRE) -- Alternus Clean Energy, Inc. (NASDAQ: ALCE) (“Alternus” or the “Company”), a leading utility-scale transatlantic, clean energy independent power producer (IPP) today announced the signing of definitive agreements with a U.S. based fund to acquire over 80 MWp of operating portfolio spanning across the U.S. The Portfolio consists of 33 projects, distributed across eight states, showcasing a geographical diversification within the U.S. The portfolio has significant long-term agreements (average remaining term of over 12 years) with 16 different counterparties. Notably, approximately 20% of these fall within the AAA and AA rating categories, such as Duke Energy, enhancing the financial stability and predictability of revenue streams. The Portfolio is expected to generate an average of $6.7 million of revenue and $5.1 million (before improvements) of operating income annually and represents a
Novo Nordisk A/S - share repurchase programme1.5.2024 14:30:46 CEST | Press release
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiated 6 February 2024, Novo Nordisk will repurchase B shares for an amount up to DKK 2.1 billion in the period from 6 February 2024 to 30 April 2024. The programme is now concluded. Since the announcement 22 April 2024, the following transactions have been made: Number of B sharesAverage purchase priceTransaction value, DKKAccumulated, last announcement2,133,5001,846,074,35122 April 202442,000859.5736,101,80523 April 202442,000881.9837,043,21124 April 202441,000885.2536,295,24925 April 202441,00